These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 39253925

  • 1. Murraya koenigii (L.) Spreng. as a Natural Intervention for Diabesity: A Review.
    Jachak SM, Thakur MS, Ahirrao P, Goyal A.
    Curr Pharm Des; 2024; 30(41):3255-3275. PubMed ID: 39253925
    [Abstract] [Full Text] [Related]

  • 2. An alkaloid enriched fraction from Murraya koenigii (L.) Spreng. Leaves ameliorate HFD-induced obesity and metabolic complexities in C57BL/6J mice.
    Thakur MS, Deshmukh KN, Dey A, Ranjan D, Goyal A, Jachak SM.
    J Ethnopharmacol; 2024 Oct 28; 333():118423. PubMed ID: 38878841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial effect of the leaves of Murraya koenigii (Linn.) Spreng (Rutaceae) on diabetes-induced renal damage in vivo.
    Yankuzo H, Ahmed QU, Santosa RI, Akter SF, Talib NA.
    J Ethnopharmacol; 2011 Apr 26; 135(1):88-94. PubMed ID: 21354289
    [Abstract] [Full Text] [Related]

  • 7. Phytochemical screening and antimicrobial activity of roots of Murraya koenigii (Linn.) Spreng. (Rutaceae).
    Vats M, Singh H, Sardana S.
    Braz J Microbiol; 2011 Oct 26; 42(4):1569-73. PubMed ID: 24031791
    [Abstract] [Full Text] [Related]

  • 8. Quantitative Analysis of Bioactive Carbazole Alkaloids in Murraya koenigii (L.) from Six Different Climatic Zones of India Using UPLC/MS/MS and Their Principal Component Analysis.
    Nandan S, Singh SK, Singh P, Bajpai V, Mishra AK, Joshi T, Mahar R, Shukla SK, Mishra DK, Kanojiya S.
    Chem Biodivers; 2021 Dec 26; 18(12):e2100557. PubMed ID: 34643999
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effect of Beta blocker-Atenolol and Murraya koenigii (L.) spreng (Curry leaves) on cardiac enzyme (CK-MB) level in male albino rats.
    Butt A, Waris N, Baqa K, Nazim U, Naz A, Abbasi SR, Begum S.
    Pak J Pharm Sci; 2019 Jul 26; 32(4):1643-1648. PubMed ID: 31608885
    [Abstract] [Full Text] [Related]

  • 11. Phytochemical portfolio and anticancer activity of Murraya koenigii and its primary active component, mahanine.
    Samanta SK, Kandimalla R, Gogoi B, Dutta KN, Choudhury P, Deb PK, Devi R, Pal BC, Talukdar NC.
    Pharmacol Res; 2018 Mar 26; 129():227-236. PubMed ID: 29175114
    [Abstract] [Full Text] [Related]

  • 12. Anti-Diabetic Potential of Murraya Koenigii (L.) and its Antioxidant Capacity in Nicotinamide-Streptozotocin Induced Diabetic Rats.
    Husna F, Suyatna FD, Arozal W, Poerwaningsih EH.
    Drug Res (Stuttg); 2018 Nov 26; 68(11):631-636. PubMed ID: 29801176
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity and Proteasome Inhibition by Alkaloid Extract from Murraya koenigii Leaves in Breast Cancer Cells-Molecular Docking Studies.
    Ismail A, Noolu B, Gogulothu R, Perugu S, Rajanna A, Babu SK.
    J Med Food; 2016 Dec 26; 19(12):1155-1165. PubMed ID: 27982755
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of antibacterial and cytotoxic activity of Artemisia nilagirica and Murraya koenigii leaf extracts against mycobacteria and macrophages.
    Naik SK, Mohanty S, Padhi A, Pati R, Sonawane A.
    BMC Complement Altern Med; 2014 Mar 05; 14():87. PubMed ID: 24597853
    [Abstract] [Full Text] [Related]

  • 15. Augmented primary humoral immune response and decreased cell-mediated immunity by Murraya koenigii in rats.
    Kaur I, Bhatia S, Bhati Y, Sharma V, Mediratta PK, Bhattacharya SK.
    J Basic Clin Physiol Pharmacol; 2014 May 01; 25(2):211-5. PubMed ID: 24129104
    [Abstract] [Full Text] [Related]

  • 16. Anti-diabetic effect of Murraya koenigii (L) and Olea europaea (L) leaf extracts on streptozotocin induced diabetic rats.
    El-Amin M, Virk P, Elobeid MA, Almarhoon ZM, Hassan ZK, Omer SA, Merghani NM, Daghestani MH, Al-Olayan EM.
    Pak J Pharm Sci; 2013 Mar 01; 26(2):359-65. PubMed ID: 23455208
    [Abstract] [Full Text] [Related]

  • 17. Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis.
    Arun A, Patel OPS, Saini D, Yadav PP, Konwar R.
    Biomed Pharmacother; 2017 Sep 01; 93():510-521. PubMed ID: 28675857
    [Abstract] [Full Text] [Related]

  • 18. Bioactive carbazole alkaloids from Murraya koenigii (L.) Spreng.
    Ma Q, Tian J, Yang J, Wang A, Ji T, Wang Y, Su Y.
    Fitoterapia; 2013 Jun 01; 87():1-6. PubMed ID: 23500386
    [Abstract] [Full Text] [Related]

  • 19. Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive Compounds.
    Balakrishnan R, Vijayraja D, Jo SH, Ganesan P, Su-Kim I, Choi DK.
    Antioxidants (Basel); 2020 Jan 24; 9(2):. PubMed ID: 31991665
    [Abstract] [Full Text] [Related]

  • 20. The hypoglycaemic effect of curry leaves (Murraya Koenigii spreng).
    Math MV, Balasubramaniam P.
    Indian J Physiol Pharmacol; 2005 Apr 24; 49(2):241-2. PubMed ID: 16170995
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.